Logo image of TRON

TRON INC (TRON) Stock Fundamental Analysis

NASDAQ:TRON - US85237B1017 - Common Stock

5.215 USD
+0.04 (+0.68%)
Last: 8/22/2025, 8:00:02 PM
5.24 USD
+0.03 (+0.48%)
After Hours: 8/22/2025, 8:00:02 PM
Fundamental Rating

1

Taking everything into account, TRON scores 1 out of 10 in our fundamental rating. TRON was compared to 31 industry peers in the Leisure Products industry. TRON has a bad profitability rating. Also its financial health evaluation is rather negative. TRON does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year TRON was profitable.
TRON had a negative operating cash flow in the past year.
TRON Yearly Net Income VS EBIT VS OCF VS FCFTRON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 2M -2M 4M -4M 6M

1.2 Ratios

With an excellent Return On Assets value of 12.69%, TRON belongs to the best of the industry, outperforming 96.77% of the companies in the same industry.
Industry RankSector Rank
ROA 12.69%
ROE N/A
ROIC N/A
ROA(3y)2.01%
ROA(5y)N/A
ROE(3y)1.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TRON Yearly ROA, ROE, ROICTRON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 5 -5 10

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for TRON so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TRON Yearly Profit, Operating, Gross MarginsTRON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

TRON has less shares outstanding than it did 1 year ago.
There is no outstanding debt for TRON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TRON Yearly Shares OutstandingTRON Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M
TRON Yearly Total Debt VS Total AssetsTRON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M

2.2 Solvency

TRON has an Altman-Z score of 4.52. This indicates that TRON is financially healthy and has little risk of bankruptcy at the moment.
TRON has a Altman-Z score of 4.52. This is in the better half of the industry: TRON outperforms 74.19% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 4.52
ROIC/WACCN/A
WACCN/A
TRON Yearly LT Debt VS Equity VS FCFTRON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.01 indicates that TRON may have some problems paying its short term obligations.
TRON's Current ratio of 0.01 is on the low side compared to the rest of the industry. TRON is outperformed by 93.55% of its industry peers.
TRON has a Quick Ratio of 0.01. This is a bad value and indicates that TRON is not financially healthy enough and could expect problems in meeting its short term obligations.
TRON has a worse Quick ratio (0.01) than 93.55% of its industry peers.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
TRON Yearly Current Assets VS Current LiabilitesTRON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 129.57% over the past year.
EPS 1Y (TTM)129.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%112.45%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 65.19, the valuation of TRON can be described as expensive.
TRON's Price/Earnings is on the same level as the industry average.
TRON's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.24.
Industry RankSector Rank
PE 65.19
Fwd PE N/A
TRON Price Earnings VS Forward Price EarningsTRON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TRON Per share dataTRON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 -0.1 -0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

TRON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TRON INC

NASDAQ:TRON (8/22/2025, 8:00:02 PM)

After market: 5.24 +0.03 (+0.48%)

5.215

+0.04 (+0.68%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners13.92%
Inst Owner Change-61.09%
Ins Owners24.12%
Ins Owner Change0%
Market Cap174.55M
Analysts0
Price TargetN/A
Short Float %19.37%
Short Ratio1.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 65.19
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.08
EY1.53%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS-0.18
TBVpS-0.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.69%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)2.01%
ROA(5y)N/A
ROE(3y)1.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z 4.52
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)129.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%112.45%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y72.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y99.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y99.89%
OCF growth 3YN/A
OCF growth 5YN/A